As of May 22
| +0.60 / +0.72%|
The 11 analysts offering 12-month price forecasts for DaVita HealthCare Partners Inc have a median target of 85.00, with a high estimate of 96.00 and a low estimate of 60.00. The median estimate represents a +1.08% increase from the last price of 84.09.
The current consensus among 16 polled investment analysts is to Hold stock in DaVita HealthCare Partners Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.